GlobalData’s “Parkinson’s Disease Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

1. Parkinson’s Disease Global Clinical Trials Review, H2,
2011
Published:October 2011
No. of Pages:119
Price:$1000
Parkinson’s Disease Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2,
2011" provides data on the Parkinson’s Disease clinical trial scenario. This report
provides elemental information and data relating to the clinical trials on
Parkinson’s Disease. It includes an overview of the trial numbers and their
recruitment status as per the site of trial conduction across the globe. The databook
offers a preliminary coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to the number of trials
for the key drugs for treating Parkinson’s Disease. This report is built using data and
information sourced from proprietary databases, primary and secondary research and
in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability
and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central
America, Europe, Middle-East and Africa and Asia-pacific and top five national
contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited
and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment,
location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe

2. - Espy the commercial landscape of the major Universities / Institutes / Hospitals or
Companies
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Parkinson’s Disease 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Parkinson’s Disease 25
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Parkinson’s Disease Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Boehringer Ingelheim GmbH 37
Clinical Trial Overview of Boehringer Ingelheim GmbH 37
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
UCB S.A. 43
Clinical Trial Overview of UCB S.A. 43
Kyowa Hakko Kirin Co., Ltd. 45
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 45
Teva Pharmaceutical Industries Limited 47
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 47
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Abbott Laboratories 51

3. Clinical Trial Overview of Abbott Laboratories 51
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
Eisai Inc. 54
Clinical Trial Overview of Eisai Inc. 54
IMPAX Laboratories, Inc. 55
Clinical Trial Overview of IMPAX Laboratories, Inc. 55
Pfizer Inc. 56
Clinical Trial Overview of Pfizer Inc. 56
Eli Lilly and Company 57
Clinical Trial Overview of Eli Lilly and Company 57
Orion Corporation 58
Clinical Trial Overview of Orion Corporation 58
EMD Serono, Inc. 59
Clinical Trial Overview of EMD Serono, Inc. 59
ACADIA Pharmaceuticals Inc. 60
Clinical Trial Overview of ACADIA Pharmaceuticals Inc. 60
Biogen Idec Inc. 61
Clinical Trial Overview of Biogen Idec Inc. 61
Newron Pharmaceuticals S.p.A. 62
Clinical Trial Overview of Newron Pharmaceuticals S.p.A. 62
Otsuka Pharmaceutical Co., Ltd. 63
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 63
Dainippon Sumitomo Pharma Co., Ltd. 64
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 64
Sanofi 65
Clinical Trial Overview of Sanofi 65
Clinical Trial Overview of Top Universities / Institutes / Hospitals 66
National Institute of Neurological Disorders and Stroke 66
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 66
Institute for Neurodegenerative Disorders 68
Clinical Trial Overview of Institute for Neurodegenerative Disorders 68
Oregon Health and Science University 70
Clinical Trial Overview of Oregon Health and Science University 70
Radboud University 71
Clinical Trial Overview of Radboud University 71
Washington University School of Medicine 72
Clinical Trial Overview of Washington University School of Medicine 72
University of Rochester 73
Clinical Trial Overview of University of Rochester 73
Vanderbilt University 74
Clinical Trial Overview of Vanderbilt University 74
Dresden University of Technology 75
Clinical Trial Overview of Dresden University of Technology 75
Baylor College of Medicine 76

4. Clinical Trial Overview of Baylor College of Medicine 76
The University of South Florida 77
Clinical Trial Overview of The University of South Florida 77
Institut National de la Sante et de la Recherche Medicale 78
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 78
UNIVERSITY HOSPITAL, CLERMONT-FERRAND 79
Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND 79
University of Florida 80
Clinical Trial Overview of University of Florida 80
Tel-Aviv Sourasky Medical Center 81
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 81
University of Minnesota 82
Clinical Trial Overview of University of Minnesota 82
University of Medicine and Dentistry New Jersey 83
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 83
Rush University Medical Center 84
Clinical Trial Overview of Rush University Medical Center 84
University of Colorado 85
Clinical Trial Overview of University of Colorado 85
University Hospital, Toulouse 86
Clinical Trial Overview of University Hospital, Toulouse 86
Seoul National University Hospital 87
Clinical Trial Overview of Seoul National University Hospital 87
Five Key Clinical Profiles 88
Appendix 115
Abbreviations 115
Definitions 115
Research Methodology 117
Secondary Research 117
About GlobalData 118
Contact Us 118
Disclaimer 118
Source 119
Latest Research Reports:
 The Indian Mining Industry – Market Opportunities and Entry
Strategies, Analyses and Forecasts to 2015
 Abbott Medical Device Company Intelligence Report
 Nihon Kohden Medical Device Company Intelligence Report
 Global OCTG (Oil Country Tubular Goods) Market Report: 2011
Edition
 Global Luxury Goods Market Report: 2011 Edition

5.  US Pharmacy Benefit Management (PBM) Industry Report: 2011
Edition
 Global OCTG (Oil Country Tubular Goods) Market Report: 2011
Edition
About Us:
MarketReportsOnline is comprising of an online library of 50,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific websites.
We provide 24/7 online and offline support to our customers. Get in touch with us for
your needs of market research reports.
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com
http://marketreportsonline.com/